Bridges Investment Management Inc. Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Bridges Investment Management Inc. bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,190 shares of the company’s stock, valued at approximately $310,000.

Several other hedge funds also recently bought and sold shares of the company. Intech Investment Management LLC acquired a new position in Option Care Health in the 2nd quarter worth about $1,014,000. MQS Management LLC acquired a new position in Option Care Health in the 2nd quarter worth about $249,000. XTX Topco Ltd acquired a new position in Option Care Health in the 2nd quarter worth about $973,000. First Eagle Investment Management LLC increased its position in Option Care Health by 33.0% in the 2nd quarter. First Eagle Investment Management LLC now owns 214,537 shares of the company’s stock worth $5,943,000 after purchasing an additional 53,250 shares during the last quarter. Finally, Seven Eight Capital LP boosted its stake in shares of Option Care Health by 100.7% during the 2nd quarter. Seven Eight Capital LP now owns 94,088 shares of the company’s stock worth $2,606,000 after acquiring an additional 47,217 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $31.90 on Monday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The firm has a market cap of $5.54 billion, a price-to-earnings ratio of 20.99, a P/E/G ratio of 2.46 and a beta of 1.29. The business’s 50-day simple moving average is $31.20 and its 200-day simple moving average is $30.44. Option Care Health, Inc. has a 52 week low of $26.11 and a 52 week high of $34.63.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. The firm had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company’s revenue was up 14.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.63 EPS. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on OPCH shares. Barrington Research increased their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. JMP Securities started coverage on Option Care Health in a report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 price objective on the stock.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.